I. Litvan

I. Litvan, K. Duff, A. Gerstenecker, 2014, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

What are the Obstacles for an Accurate Clinical Diagnosis of Pick's disease?

K. Jellinger, J. Jankovic, I. Litvan, 1998, Neurology.

4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration

D. Galasko, D. Dickson, B. Ghetti, 2019, Acta Neuropathologica.

A lack of the R406W tau mutation in progressive supranuclear palsy and corticobasal degeneration

I. Litvan, J. Higgins, L. Nee, 1999, Neurology.

Brain-Lung-Thyroid Disease

I. Litvan, O. Adam, D. Houghton, 2012, Journal of child neurology.

Closing the loop for patients with Parkinson disease: where are we?

Kuldeep Mahato, I. Litvan, J. Sempionatto, 2022, Nature Reviews Neurology.

Comparison of depression, anxiety and quality of life in PSP and MSA

Andrew J. Lees, Anthony E. Lang, Marjan Jahanshahi, 2009 .

Wearable Electrochemical Microneedle Sensing Platform for Real-Time Continuous Interstitial Fluid Monitoring of Apomorphine: Toward Parkinson Management

Kuldeep Mahato, I. Litvan, Joseph Wang, 2021, Sensors and Actuators B: Chemical.

Estimating the Evolution of Disease in the Parkinson’s Progression Markers Initiative

W. Thompson, P. Aisen, M. Donohue, 2018, Neurodegenerative Diseases.

Differences in Motor Features of C9orf72, MAPT, or GRN Variant Carriers With Familial Frontotemporal Lobar Degeneration

David T. Jones, D. Geschwind, B. Dickerson, 2022, Neurology.

Sensitivity of the Social Behavior Observer Checklist to Early Symptoms of Patients With Frontotemporal Dementia

K. Rankin, B. Dickerson, B. Boeve, 2022, Neurology.

Identiﬁcation of a Novel Risk Locus for Progressive Supranuclear Palsy by a Pooled Genomewide Scan of 500,288 Single-Nucleotide Polymorphisms

Jason J. Corneveaux, D. Stephan, S. Melquist, 2007 .

Physical activity intensity is associated with cognition and functional connectivity in Parkinson's disease.

J. V. Van Horn, I. Litvan, G. Petzinger, 2022, Parkinsonism & related disorders.

Plasma Neuro ﬁ lament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration

Sheng-Yang M. Goh, A. Toga, L. Petrucelli, 2022 .

Temporal order of clinical and biomarker changes in familial frontotemporal dementia

Jennifer M. Nicholas, Sheng-Yang M. Goh, M. Freedman, 2022, Nature Medicine.

Pupillary diameter assessment: Need for a graded scale

I Litvan, J J Bartko, J. Bartko, 2000, Neurology.

Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders

David T. Jones, A. Fagan, L. Petrucelli, 2022, Cell reports. Medicine.

Lrrk2 and Lewy body disease

Irene Litvan, Deborah C Mash, Dennis W Dickson, 2006, Annals of neurology.

Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms.

Richard J Caselli, John V Pearson, Irene Litvan, 2007, American journal of human genetics.

Accuracy of the Clinical Diagnosis of Corticobasal Degeneration

J. P. Brandel, K. Jellinger, J. Jankovic, 1997, Neurology.

A Pilot Randomized Controlled Trial Investigating MBSR for Parkinson’s Disease Patients and Their Caregiving Partners: Effects on Distress, Social support, Cortisol, and Inflammation

I. Litvan, P. Salmon, S. Sephton, 2022, Mindfulness.

Nicked tRNAs are stable reservoirs of tRNA halves in cells and biofluids

M. Calzi, P. Ivanov, I. Litvan, 2022, bioRxiv.

Functional topologies of spatial cognition predict cognitive and motor progression in Parkinson’s

Roland R. Lee, D. Harrington, Mingxiong Huang, 2022, Frontiers in Aging Neuroscience.

Cerebrospinal fluid acetylcholinesterase in progressive supranuclear palsy: reduced activity relative to normal subjects and lack of inhibition by oral physostigmine.

L. Thal, S. Rapoport, I. Litvan, 1991, Journal of neurology, neurosurgery, and psychiatry.

Roles of Education and IQ in Cognitive Reserve in Parkinson's Disease-Mild Cognitive Impairment

G. Naglie, P. Eslinger, I. Litvan, 2012, Dementia and Geriatric Cognitive Disorders Extra.

CEREBELLAR COGNITION. AUTHOR' REPLY

M. Hallett, J. Grafman, I. Litvan, 1993 .

Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across Tauopathies.

J. Trojanowski, M. Grossman, Douglas Galasko, 2022, Journal of neuropathology and experimental neurology.

Nonlinear Z-score modeling for improved detection of cognitive abnormality

David T. Jones, Lilah M. Besser, A. Toga, 2019, Alzheimer's & dementia.

Alzheimer's disease presenting as corticobasal syndrome

J. Grafman, D. Dickson, I. Litvan, 2006, Movement disorders : official journal of the Movement Disorder Society.

Differential impact of individual autonomic domains on clinical outcomes in Parkinson’s disease

I. Litvan, L. Lopiano, F. Vallelonga, 2022, Journal of Neurology.

Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study.

T. Gillis, M. MacDonald, H. Shill, 2006, Archives of neurology.

Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration

Sheng-Yang M. Goh, A. Toga, L. Petrucelli, 2021, Neurology.

Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration

Bradford C. Dickerson, Bruce L. Miller, Murray Grossman, 2020, Nature Medicine.

The FAB: A frontal assessment battery at bedside

I Litvan, B. Dubois, B. Pillon, 2000, Neurology.

Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint

David T. Jones, Sheng-Yang M. Goh, A. Toga, 2019, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Annonacin in Asimina triloba fruit: implication for neurotoxicity.

I. Litvan, M. Hetman, Lisa F. Potts, 2012, Neurotoxicology.

Occupation and Parkinson disease in the Women's Health Initiative Observational Study.

A. LaCroix, R. Wallace, I. Litvan, 2019, American journal of industrial medicine.

Occupation and Parkinson disease in Women’s Health Initiative Observational Study

A. LaCroix, R. Wallace, I. Litvan, 2019, bioRxiv.

What can preservation of autobiographic memory after muscarinic blockade tell us about the scopolamine model of dementia?

A. Sirigu, J. Grafman, I. Litvan, 1995, Neurology.

Wearable Electrochemical Microneedle Sensor for Continuous Monitoring of Levodopa: Toward Parkinson Management.

Roger Narayan, Joseph Wang, Irene Litvan, 2019, ACS sensors.

A disposable electrochemical biosensor for l-DOPA determination in undiluted human serum

I. Litvan, G. Valdés-Ramírez, Joseph Wang, 2014 .

Selective Deficits in Alzheimer and Parkinsonian Dementia: Visuospatial Function

I. Litvan, E. Mohr, T. Chase, 1990, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Supranuclear gaze palsy and eyelid apraxia in postencephalitic parkinsonism

K. Jellinger, I. Litvan, G. Wenning, 2005, Journal of Neural Transmission.

Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study.

K. Jellinger, J. Jankovic, Y. Agid, 1998, Archives of neurology.

Validation of the MDS clinical diagnostic criteria for Parkinson's disease

W. Poewe, A. Lang, R. Postuma, 2018, Movement disorders : official journal of the Movement Disorder Society.

Review article Progressive supranuclear palsy revisited

I. Litvan, 1998, Acta Neurologica Scandinavica.

Dissociation of Neural Mechanisms for Intersensory Timing Deficits in Parkinson's Disease.

Deborah L. Harrington, Roland R. Lee, Irene Litvan, 2014, Timing & time perception.

Selective deficits in cognition and memory in high-functioning parkinsonian patients.

I Litvan, I. Litvan, E. Mohr, 1990, Journal of neurology, neurosurgery, and psychiatry.

Does reversed laterality really exist in dextrals? A case study

C. Junqué, I. Litvan, P. Vendrell, 1986, Neuropsychologia.

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

Stephanie D. Wilson, S. Ellias, J. Nutt, 2014, JAMA neurology.

Transcriptional analysis of peripheral memory T cells reveals Parkinson’s disease-specific gene signatures

Bjoern Peters, A. Sette, D. Sulzer, 2021, npj Parkinson's Disease.

α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease

S. Mallal, K. Marder, Bjoern Peters, 2020, Nature Communications.

Frontrunner in Translation: Progressive Supranuclear Palsy

I. Litvan, A. Shoeibi, N. Olfati, 2019, Front. Neurol..

Identification of common variants influencing risk of the tauopathy Progressive Supranuclear Palsy

Andrew J. Lees, Allissa Dillman, Li-San Wang, 2011, Nature Genetics.

Haplotypes and gene expression implicate the MAPT region for Parkinson disease

H. Shill, J. Growdon, S. Sherman, 2008, Neurology.

Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial

S. Haeberlein, A. Lang, M. Grundman, 2021, Nature Medicine.

Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration

K. Blennow, B. Dickerson, D. Airey, 2020, Nature Medicine.

Diagnosis and management of dementia with Lewy bodies

S Minoshima, J Q Trojanowski, J Hardy, 2005, Neurology.

Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.

C. Tanner, A. Lang, A. Fasano, 2019, Neurology.

Transcriptional analysis of peripheral memory T cells reveals Parkinson’s disease-specific gene signatures

Bjoern Peters, A. Sette, D. Sulzer, 2022, npj Parkinson's Disease.

Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options

J. Lucas, K. Frey, B. Landwehrmeyer, 2009, European journal of neurology.

Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials

I. Litvan, G. Imbalzano, A. Merola, 2021, Frontiers in Neurology.

Evaluation of surgery for Parkinson’s disease

M. Hallett, I. Litvan, 1999, Neurology.

Apathy is not depression.

Jane S. Paulsen, I Litvan, B L Miller, 1998, The Journal of neuropsychiatry and clinical neurosciences.

Cognitive and behavioral aspects of PSP since Steele, Richardson and Olszewski’s description of PSP 40 years ago and Albert’s delineation of the subcortical dementia 30 years ago

I. Litvan, A. Magherini, 2005, Neurocase.

Cognitive disturbances in progressive supranuclear palsy.

I. Litvan, Irene Litvan, 1994, Journal of neural transmission. Supplementum.

Phosphorylated α-Synuclein in Parkinson’s Disease

J. Trojanowski, D. Galasko, V. Lee, 2012, Science Translational Medicine.

α‐synuclein genetic variability: A biomarker for dementia in Parkinson disease

Ekaterina Nosova, Irene Litvan, Laura Parkkinen, 2016, Annals of neurology.

Progressive supranuclear palsy: Advances in diagnosis and management.

I. Litvan, D. Coughlin, 2020, Parkinsonism & related disorders.

Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches

A. Lang, A. Boxer, I. Litvan, 2017, The Lancet Neurology.

Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial.

D. Mozaffarian, Z. Mari, H. Shill, 2021, JAMA.

Consensus statement on the diagnosis of multiple system atrophy

I Litvan, Y Ben-Shlomo, S Gilman, 1998, Journal of the Neurological Sciences.

The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy

Wayne A. Gordon, Ann C. McKee, Irene Litvan, 2015, Acta Neuropathologica.

The RAB39B p.G192R mutation causes X-linked dominant Parkinson’s disease

M. Dorschner, A. Samii, S. Factor, 2015, Molecular Neurodegeneration.

Title The RAB 39 B p . G 192 R mutation causes X-linked dominant Parkinson ' s disease Permalink

M. Dorschner, A. Samii, S. Factor, 2015 .

Bilateral subthalamotomy in Parkinson's disease: initial and long-term response.

I Litvan, J A Obeso, M R DeLong, 2005, Brain : a journal of neurology.

“Applause sign” helps to discriminate PSP from FTD and PD

B. Dubois, B. Pillon, A. Slachevsky, 2005, Neurology.

Long-duration Parkinson's disease: role of lateralization of motor features.

I. Litvan, F. Morgante, A. Espay, 2013, Parkinsonism & related disorders.

Hispanic Perspectives on Parkinson’s Disease Care and Research Participation

H. Shill, I. Litvan, E. Bayram, 2021, Journal of Alzheimer's disease : JAD.

Accuracy of the clinical diagnosis of postencephalitic parkinsonism: a clinicopathologic study

K. Jellinger, J. Jankovic, Y. Agid, 1998, European journal of neurology.

α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease

S. Mallal, K. Marder, Bjoern Peters, 2020, Nature Communications.

A phase 2 trial of the GSK‐3 inhibitor tideglusib in progressive supranuclear palsy

E. Tolosa, D. Burn, A. Lees, 2014, Movement disorders : official journal of the Movement Disorder Society.

Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy

Murray Grossman, Jordan Grafman, Nilüfer Ertekin-Taner, 2015, Nature Communications.

Research goals in progressive supranuclear palsy

M. Hallett, G. Schellenberg, B. Dubois, 2000, Movement disorders : official journal of the Movement Disorder Society.

Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force

E. Tolosa, B. Dubois, W. Poewe, 2007, Movement disorders : official journal of the Movement Disorder Society.

Behcet's syndrome masquerading as tumor

À. Rovira, I. Litvan, J. Ruscalleda, 2004, Neuroradiology.

Time to Redefine PD? Introductory Statement of the MDS Task Force on the Definition of Parkinson's Disease

G. Deuschl, J. Hardy, B. Dubois, 2014, Movement disorders : official journal of the Movement Disorder Society.

Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease.

I. Litvan, E. Mohr, T. Chase, 1991, Journal of neurology, neurosurgery, and psychiatry.

Alzheimer ' s disease . in demented patients with Parkinson ' s and Differential memory and executive functions

I. Litvan, E. Mohr, T. Chase, 2022 .

Effects of closed traumatic brain injury and genetic factors on the development of Alzheimer’s disease

K. Jellinger, I. Litvan, W. Paulus, 2001, European journal of neurology.

The Second NINDS/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy

Kevin F. Bieniek, D. Perl, P. Bellgowan, 2021, Journal of neuropathology and experimental neurology.

Progression of Microstructural Degeneration in Progressive Supranuclear Palsy and Corticobasal Syndrome: A Longitudinal Diffusion Tensor Imaging Study

N. Schuff, B. Dickerson, H. Rosen, 2016, PloS one.

18F‐flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study

Keith A. Johnson, Daniel R. Schonhaut, W. Jagust, 2017, Annals of neurology.

MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI

C. Adler, A. Tröster, J. Kulisevsky, 2011, Movement disorders : official journal of the Movement Disorder Society.

CSF galanin and neuropeptide Y immunoreactivity in progressive supranuclear palsy

I. Litvan, T. Chase, J. Atack, 1992, Acta neurologica Scandinavica.

PROGRESSIVE SUPRANUCLEAR PALSY: STARING INTO THE PAST, MOVING INTO THE FUTURE

I Litvan, A J Lees, A. Lees, 1998 .

Sex differences for phenotype in pathologically defined dementia with Lewy bodies

I. Litvan, E. Bayram, S. Banks, 2021, Journal of Neurology, Neurosurgery, and Psychiatry.

Traumatic brain injury as a risk factor for Alzheimer disease. Comparison of two retrospective autopsy cohorts with evaluation of ApoE genotype

K. Jellinger, I. Litvan, W. Paulus, 2001, BMC neurology.

Neuropsychiatric features of corticobasal degeneration

M. Mega, J. Cummings, I. Litvan, 1998, Journal of neurology, neurosurgery, and psychiatry.

Corticobasal Degeneration

I. Litvan, Ana Grijalvo-Perez, 2014, Seminars in Neurology.

Therapeutic options for Progressive Supranuclear Palsy including investigational drugs

I. Litvan, A. Shoeibi, 2017 .

Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium

David T. Jones, A. Toga, L. Petrucelli, 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Clinicopathologic subtype of Alzheimer's disease presenting as corticobasal syndrome

M. Murray, D. Dickson, R. Uitti, 2019, Alzheimer's & Dementia.

Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia

K. Rankin, B. Dickerson, B. Boeve, 2021, Cortex.

Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases

A. Toga, L. Petrucelli, J. Trojanowski, 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Movement disorder society criteria for clinically established early Parkinson's disease

Günther Deuschl, Bastiaan R Bloem, Inga Liepelt-Scarfone, 2018, Movement disorders : official journal of the Movement Disorder Society.

Fall Prediction and Prevention Systems: Recent Trends, Challenges, and Future Research Directions

Tzyy-Ping Jung, Ramesh Rajagopalan, Irene Litvan, 2017, Sensors.

ASLPrep: a platform for processing of arterial spin labeled MRI and quantification of regional brain perfusion

Maxwell A. Bertolero, Matthew W Flounders, Phillip A. Cook, 2022, Nature Methods.

End of life planning in parkinsonian diseases.

I. Litvan, Danielle M. Gillard, J. Proudfoot, 2019, Parkinsonism & related disorders.

Scales to Assess Clinical Features of Progressive Supranuclear Palsy: MDS Task Force Report

G. Stebbins, C. Goetz, P. Martínez-Martín, 2015, Movement disorders clinical practice.

Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration

David T. Jones, Sheng-Yang M. Goh, A. Toga, 2019, Alzheimer's & Dementia.

The contribution of behavioral features to caregiver burden in FTLD spectrum disorders

B. Dickerson, B. Boeve, M. Grossman, 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Assessment of cognition in early dementia

Joel H. Kramer, Ronald C. Petersen, Brian R. Ott, 2011, Alzheimer's & Dementia.

Changes in Self- and Informant-Reported Frontal Behaviors in Parkinson’s Disease: A Longitudinal Study

J. Filoteo, I. Litvan, S. Lessig, 2020, Journal of geriatric psychiatry and neurology.

Clinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status.

Lilah M. Besser, W. Kukull, I. Litvan, 2014, Parkinsonism & related disorders.

Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration

David T. Jones, Sheng-Yang M. Goh, A. Toga, 2019, Alzheimer's & Dementia.

Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium

David T. Jones, A. Toga, L. Petrucelli, 2019, Alzheimer's & Dementia.

Behavioral abnormalities in progressive supranuclear palsy

I. Litvan, K. Duff, A. Gerstenecker, 2013, Psychiatry Research.

Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease.

I Litvan, D. Aarsland, I. Litvan, 2001, The Journal of neuropsychiatry and clinical neurosciences.

Neuropsychiatric aspects of progressive supranuclear palsy

Jeffrey L. Cummings, Irene Litvan, Michael S. Mega, 1996, Neurology.

Title Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy : A case control study

M. Farrer, D. Dickson, S. Rai, 2012 .

Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy: a case control study

M. Farrer, D. Dickson, S. Rai, 2012, BMC Medical Genetics.

Randomized placebo-controlled trial of donepezil in patients with progressive supranuclear palsy

M. Hallett, J. Grafman, I. Litvan, 2001, Neurology.

Clinical-Neuropathological Correlations of Alzheimer's Disease and Related Dementias in Latino Volunteers.

D. Salmon, D. Galasko, J. Brewer, 2018, Journal of Alzheimer's disease : JAD.

Implicit learning in patients with Alzheimer's disease.

J. Grafman, H. Weingartner, I. Litvan, 1990, Pharmacopsychiatry.

Consensus report of the working group on: 'Molecular and biochemical markers of Alzheimer's disease'

Giovanni B. Frisoni, Alfredo Robles, Takeshi Iwatsubo, 1998 .

Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort

S. Anderson, K. Marder, M. Mcdermott, 2009, Neurology.

The Role of Stress as a Risk Factor for Progressive Supranuclear Palsy.

D. Standaert, S. Edland, I. Litvan, 2017, Journal of Parkinson's disease.

Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease

D. Aarsland, K. Hawkins, A. Siderowf, 2020, Annals of clinical and translational neurology.

Cognitive and neuropsychiatric effects of subthalamotomy for Parkinson's disease.

J. Obeso, M. Rodriguez-Oroz, J. Guridi, 2010, Parkinsonism & related disorders.

Progression of brain atrophy in PSP and CBS over 6 months and 1 year

Richard J. Binney, C. Jack, N. Schuff, 2016, Neurology.

Diagnostic issues in non-AD dementias

I. Litvan, T. Perry, 2004, Clinical Neuroscience Research.

Progressive supranuclear gaze palsy is in linkage disequilibrium with theτ and not the α-synuclein gene

I. Litvan, J. Higgins, L. Nee, 1998, Neurology.

Parkinson’s Disease: An Overview of Pathogenesis

I. Litvan, P. Chand, 2009 .

The Etiopathogenesis of Parkinson Disease and Suggestions for Future Research. Part II

M. Hallett, M. Chesselet, D. Price, 2007, Journal of neuropathology and experimental neurology.

Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders.

Jane S. Paulsen, M. Mega, J. Cummings, 1998, Archives of neurology.

Genetic influences on cognition in progressive supranuclear palsy

G. Schellenberg, D. Standaert, I. Litvan, 2017, Movement disorders : official journal of the Movement Disorder Society.

Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal Syndrome

B. Dickerson, M. Grossman, J. Kramer, 2023, JAMA neurology.

Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration

Johannes Dichgans, Till-Karsten Hauser, Jörg B. Schulz, 2004, NeuroImage.

Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium

R. R. Walsh, Daniel E. Huddleston, Jee A. Bang, 2021, Frontiers in Neurology.

Neuropsychiatric aspects of corticobasal degeneration.

J. Cummings, I. Litvan, 2000, Advances in neurology.

Update on epidemiological aspects of progressive supranuclear palsy

Irene Litvan, I. Litvan, 2003, Movement disorders : official journal of the Movement Disorder Society.

Measuring mild cognitive impairment in patients with Parkinson's disease

P. Eslinger, S. Weintraub, I. Litvan, 2013, Movement disorders : official journal of the Movement Disorder Society.

Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy.

T. Ferman, I. Litvan, K. Duff, 2013, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

Plasma inflammation for predicting phenotypic conversion and clinical progression of autosomal dominant frontotemporal lobar degeneration

K. Rankin, W. Kremers, J. Kramer, 2023, Journal of Neurology, Neurosurgery, and Psychiatry.

Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy

M. Murray, D. Dickson, R. Uitti, 2019, Movement disorders : official journal of the Movement Disorder Society.

Performance on the dementia rating scale in Parkinson’s disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer’s disease

T Wentzel-Larsen, I Litvan, D. Salmon, 2003, Journal of neurology, neurosurgery, and psychiatry.

Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination

I Litvan, G K Wenning, W Poewe, 1998, Journal of neurology, neurosurgery, and psychiatry.

A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy

M. Jahanshahi, C. Mathias, A. Lang, 2010, Movement disorders : official journal of the Movement Disorder Society.

PROGRESSIVE SUPRANUCLEAR PALSY: STARING INTO THE PAST, MOVING INTO THE FUTURE

I. Litvan, 1998 .

Clinical and pathologic features of cognitive-predominant corticobasal degeneration

O. Pedraza, M. Murray, D. Dickson, 2020, Neurology.

Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype

B. Boeve, D. Dickson, R. Uitti, 2018, Acta Neuropathologica.

Parkinsonian Syndromes

I. Litvan, David R. Williams, 2013, Continuum.

Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration

K. Jellinger, J. Jankovic, A. Lang, 1999, Journal of Neurology.

Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.

I Litvan, K. Jellinger, K. Chaudhuri, 1997, Brain : a journal of neurology.

Preserved cognitive processes in cerebellar degeneration

M. Hallett, J. Grafman, J. Wachs, 1996, Behavioural Brain Research.

The Etiopathogenesis of Parkinson Disease and Suggestions for Future Research. Part I

M. Hallett, M. Chesselet, D. Price, 2007, Journal of neuropathology and experimental neurology.

Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study

Irene Litvan, Christoph Scherfler, K Ray Chaudhuri, 1999, Journal of neurology, neurosurgery, and psychiatry.

Yes/no reversals as neurobehavioral sequela: a disorder of language, praxis, or inhibitory control?

Joseph James Duffy, J. Grafman, I. Litvan, 2003, European journal of neurology.

A frontal assessment battery at bedside

Irene Litvan, Bruno Dubois, Bernard Pillon, 2000 .

Physostigmine treatment of progressive supranuclear palsy

I. Litvan, T. Chase, J. Atack, 1989, Annals of neurology.

Environmental Risk Factors for Progressive Supranuclear Palsy

I. Litvan, H. Park, S. Ilango, 2021, Journal of movement disorders.

Environmental and occupational risk factors for progressive supranuclear palsy: Case‐control study

S. Rai, I. Litvan, S. Reich, 2016, Movement disorders : official journal of the Movement Disorder Society.

Informant-Reported Cognitive Decline is Associated with Objective Cognitive Performance in Parkinson’s Disease

J. Filoteo, I. Litvan, S. Lessig, 2020, Journal of the International Neuropsychological Society.

Mild cognitive impairment as a risk factor for Parkinson's disease dementia

C. Adler, A. Tröster, D. Burn, 2017, Movement disorders : official journal of the Movement Disorder Society.

Predictors of performance-based measures of instrumental activities of daily living in nondemented patients with Parkinson’s disease

J. Filoteo, I. Litvan, S. Lessig, 2013, Journal of clinical and experimental neuropsychology.

Tanya Simuni, Irene Litvan, Darren Gitelman, 2010, Movement disorders : official journal of the Movement Disorder Society.

Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degeneration

B. Dickerson, B. Boeve, D. Knopman, 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care

Nikolaus R. McFarland, M. Mancini, M. Grossman, 2021, Frontiers in Neurology.

Importance of deficits in executive functions

J. Grafman, I. Litvan, 1999, The Lancet.

Current and future treatments in progressive supranuclear palsy

I. Litvan, Irene van Balken, 2006, Current treatment options in neurology.

Feasibility and acceptability of remote smartphone cognitive testing in frontotemporal dementia research

K. Rankin, B. Dickerson, B. Boeve, 2023, Alzheimer's & dementia.

Frontal lobe function in progressive supranuclear palsy.

J. Grafman, I. Litvan, T. Chase, 1990, Archives of neurology.

Neuropsychiatric Predictors of Cognitive Decline in Parkinson Disease: A Longitudinal Study.

J. Filoteo, I. Litvan, S. Lessig, 2017, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint

David T. Jones, Sheng-Yang M. Goh, A. Toga, 2019, Alzheimer's & Dementia.

What is an Atypical Parkinsonian Disorder

I. Litvan, 2005 .

Parkinson disease with mild cognitive impairment: Domain‐specific cognitive complaints predict dementia

P. Eslinger, S. Weintraub, I. Litvan, 2020, Acta neurologica Scandinavica.

Levodopa‐Responsive Parkinsonism Associated with Giant Virchow‐Robin Spaces: A Case Report

I. Litvan, A. Shoeibi, 2017, Movement disorders clinical practice.

Strengths and challenges in conducting clinical trials in Parkinson's disease mild cognitive impairment

A. Tröster, D. Aarsland, K. Kieburtz, 2018, Movement disorders : official journal of the Movement Disorder Society.

Memory impairment in patients with progressive supranuclear palsy.

J. Grafman, I. Litvan, T. Chase, 1989, Archives of neurology.

Pathophysiology, genetics, clinical features, diagnosis and therapeutic trials in progressive supranuclear palsy

I. Litvan, B. Bluett, 2015 .

Semantic Recollection in Parkinson’s Disease: Functional Reconfiguration and MAPT Variants

Roland R. Lee, D. Harrington, Mingxiong Huang, 2021, Frontiers in Aging Neuroscience.

The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism

Nikolaus R. McFarland, S. Cummings, C. Tanner, 2021, npj Parkinson's Disease.

The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism

Kyle T. Mitchell, Nikolaus R. McFarland, S. Cummings, 2021, npj Parkinson's Disease.

Which ante mortem clinical features predict progressive supranuclear palsy pathology?

S. Lorenzl, W. Oertel, J. Rowe, 2017, Movement disorders : official journal of the Movement Disorder Society.

H1/H1 genotype influences symptom severity in corticobasal syndrome

I. Litvan, M. Hutton, A. Cambon, 2010, Movement disorders : official journal of the Movement Disorder Society.

Reply: Corticobasal syndrome with Alzheimer's disease pathology

I. Litvan, P. Chand, 2009 .

Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study

J. Jankovic, D. Standaert, I. Litvan, 2018, Movement disorders : official journal of the Movement Disorder Society.

Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy

M. Vidailhet, C. Pierrot-Deseilligny, B. Gaymard, 2000, Neurology.

Examining the Motor Phenotype of Patients with Both Essential Tremor and Parkinson's Disease

Irene Litvan, Elan D. Louis, I. Litvan, 2012, Tremor and other hyperkinetic movements.

Agitation and Apathy in Hyper- and Hypokinetic Movement Disorders

J. Kulisevsky, I. Litvan, 2003 .

Neuropsychiatric assessment of Gilles de la Tourette patients: Comparative study with other hyperkinetic and hypokinetic movement disorders

Jane S. Paulsen, J. Kulisevsky, I. Litvan, 2001, Movement disorders : official journal of the Movement Disorder Society.

Language disturbances in corticobasal degeneration

J. Grafman, I. Litvan, N. Patronas, 2000, Neurology.

Dopamine effects on memory load and distraction during visuospatial working memory in cognitively normal Parkinson’s disease

D. Harrington, I. Litvan, E. Bayram, 2020, Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition.

Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disability.

E. Tolosa, I. Litvan, A. Shoeibi, 2019, Parkinsonism & related disorders.

Progressive supranuclear palsy: progression and survival

S. Weigand, J. Whitwell, I. Litvan, 2016, Journal of Neurology.

Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age

H. Shill, J. Growdon, D. Burn, 2006, Neurology.

Cognition among individuals along a spectrum of increased risk for Parkinson’s disease

Dag Aarsland, Daniel Weintraub, Tanya Simuni, 2018, PloS one.

Freezing of gait in postmortem‐confirmed atypical parkinsonism

W. Poewe, I. Litvan, Jörg Müller, 2002, Movement disorders : official journal of the Movement Disorder Society.

A Modified Progressive Supranuclear Palsy Rating Scale for Virtual Assessments

A. Lang, A. Boxer, I. Litvan, 2022, Movement disorders : official journal of the Movement Disorder Society.

Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations.

Bruce H. Morimoto, J. Jankovic, C. Jack, 2019, Parkinsonism & related disorders.

Multisite ALLFTD study modeling progressive empathy loss from the earliest stages of behavioral variant frontotemporal dementia

A. Toga, K. Rankin, J. Graff‐Radford, 2023, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Enrollment of Participants From Marginalized Racial and Ethnic Groups

C. Lungu, A. Lang, I. Litvan, 2023, Neurology. Clinical practice.

Cognitive Impairment in Parkinson’s Disease: Epidemiology, Clinical Profile, Protective and Risk Factors

I. Litvan, C. Marras, E. Bayram, 2021, Behavioral sciences.

Progression of gait, speech and swallowing deficits in progressive supranuclear palsy

S. Leurgans, A. Lang, C. Goetz, 2003, Neurology.

Current and future therapeutic approaches in progressive supranuclear palsy.

I. Litvan, I. van Balken, 2008, Handbook of clinical neurology.

Progressive supranuclear palsy

I Litvan, J. Grafman, I. Litvan, 1998, Neurology.

Topological reorganization of functional hubs in patients with Parkinson’s disease with freezing of gait

Z. Mari, D. Cordes, I. Litvan, 2023, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

Internetwork Connectivity Predicts Cognitive Decline in Parkinson’s and Is Altered by Genetic Variants

Roland R. Lee, D. Harrington, Mingxiong Huang, 2022, Frontiers in Aging Neuroscience.

Risk of Parkinson's disease dementia related to level I MDS PD‐MCI

C. Adler, A. Tröster, D. Burn, 2019, Movement disorders : official journal of the Movement Disorder Society.

Instrumental activities of daily living are impaired in Parkinson's disease patients with mild cognitive impairment.

J. Filoteo, I. Litvan, S. Lessig, 2014, Neuropsychology.

Orthostatic Hypotension Is Associated With Cognitive Decline in Parkinson Disease

I. Litvan, E. Bayram, K. Longardner, 2020, Frontiers in Neurology.

The role of dispositional mindfulness in a stress-health pathway among Parkinson’s disease patients and caregiving partners

J. Filoteo, I. Litvan, P. Salmon, 2019, Quality of Life Research.

Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration.

M. Hallett, N. Lundbom, G. Tedeschi, 1997, Brain : a journal of neurology.

Clinical and Genetic Aspects of Progressive Supranuclear Palsy

I. Litvan, M. Hutton, Irene Litvan, 1998, Journal of geriatric psychiatry and neurology.

Progressive supranuclear palsy

J. Grafman, Ray Johnson, I. Litvan, 1991, Neurology.

Effects of physostigmine on spatial attention in patients with progressive supranuclear palsy.

D. Robinson, C. Kertzman, I. Litvan, 1990, Archives of neurology.

Why Therapeutic Trials Fail in Primary Tauopathies

I. Litvan, E. Bayram, N. Olfati, 2023, Movement disorders : official journal of the Movement Disorder Society.

Traumatic brain injury as a risk factor for Alzheimer disease

K. Jellinger, I. Litvan, W. Paulus, 2001 .

Unilateral left cerebral deterioration documented by CT, MRI, and neuropsychological studies: A possible case of pick's disease

C. Junqué, I. Litvan, C. Roig, 1988 .

Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.

Lilah M. Besser, S. Weintraub, W. Kukull, 2016, Parkinsonism & related disorders.

Impairment of eyeblink classical conditioning in progressive supranuclear palsy

M. Hallett, J. Grafman, I. Litvan, 2001, Movement disorders : official journal of the Movement Disorder Society.

Gene-Environment Interactions in Progressive Supranuclear Palsy

G. Schellenberg, J. Jankovic, E. Martin, 2021, Frontiers in Neurology.

Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson’s Disease

P. Eslinger, S. Weintraub, I. Litvan, 2019, Dementia and Geriatric Cognitive Disorders.

Impact of Mild Cognitive Impairment on Health-Related Quality of Life in Parkinson's Disease

P. Eslinger, A. Lang, I. Litvan, 2013, Dementia and Geriatric Cognitive Disorders.

The pill questionnaire in a nondemented Parkinson's disease population

P. Eslinger, A. Lang, I. Litvan, 2012, Movement Disorders.

Measuring quality of life in PSP

A. Lang, J. Hobart, N. Quinn, 2006, Neurology.

Progressive supranuclear palsy revisited.

I. Litvan, 1998, Acta neurologica Scandinavica.

Relationship between uric acid levels and progressive supranuclear palsy

I. Litvan, B. Kluger, D. Hall, 2016, Movement disorders : official journal of the Movement Disorder Society.

Parkinsonian features: when are they Parkinson disease?

I. Litvan, 1998, JAMA.

Understanding the relationship between freezing of gait and other progressive supranuclear palsy features.

J. Jankovic, D. Standaert, I. Litvan, 2020, Parkinsonism & related disorders.

Delineation of Apathy Subgroups in Parkinson's Disease: Differences in Clinical Presentation, Functional Ability, Health‐related Quality of Life, and Caregiver Burden

J. Filoteo, I. Litvan, S. Lessig, 2020, Movement disorders clinical practice.

Assessment of Motor Dysfunction with Virtual Reality in Patients Undergoing [123I]FP-CIT SPECT/CT Brain Imaging

P. Xie, I. Litvan, Ghiam Yamin, 2021, Tomography.

high-functioning parkinsonian patients . Selective deficits in cognition and memory in

I. Litvan, E. Mohr, T. Chase, 2022 .

Rate of decline in progressive supranuclear palsy

I. Litvan, M. Kong, 2014, Movement disorders : official journal of the Movement Disorder Society.

Measuring quality of life in progressive supranuclear palsy: The PSP-QoL

A. Lang, J. Hobart, N. Quinn, 2011 .

Rapidly progressive atypical parkinsonism associated with frontotemporal lobar degeneration and motor neuron disease

B. Ghetti, I. Litvan, A. Espay, 2010, Journal of Neurology Neurosurgery & Psychiatry.

Corticobasal Degeneration and Related Disorders

A. Lang, C. Goetz, I. Litvan, 1999 .

Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine

I. Litvan, S. Lessig, F. Nahab, 2018, Neurology.

Mild cognitive impairment in Parkinson's disease.

I. Litvan, J. Goldman, 2011, Minerva medica.

Does the Geriatric Depression Scale measure depression in Parkinson's disease?

J. Filoteo, I. Litvan, S. Lessig, 2018, International journal of geriatric psychiatry.

Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment

I. McKeith, John-Paul Taylor, G. Stebbins, 2018, Movement disorders : official journal of the Movement Disorder Society.

Sex differences for cognitive decline in progressive supranuclear palsy.

T. del Ser, I. Litvan, E. Bayram, 2023, Parkinsonism & related disorders.

Comparison of apraxia in corticobasal degeneration and progressive supranuclear palsy

J. Grafman, I. Litvan, B. Uttl, 2001, Neurology.

Ideomotor apraxia in progressive supranuclear palsy: A case study

D. Brat, I. Litvan, S. Reich, 1999, Movement disorders : official journal of the Movement Disorder Society.

Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders

M. Difrancesco, Y. Shimo, R. Camicioli, 2021, Neurology.

Psychometric Properties and Characteristics of the North‐East Visual Hallucinations Interview in Parkinson's Disease

J. Filoteo, I. Litvan, S. Lessig, 2017, Movement disorders clinical practice.

The utility of the Mattis Dementia Rating Scale in Parkinson's disease mild cognitive impairment.

J. Filoteo, I. Litvan, S. Lessig, 2014, Parkinsonism & related disorders.

Factor Analysis of the Apathy Scale in Parkinson's Disease

J. Filoteo, I. Litvan, S. Lessig, 2019, Movement disorders clinical practice.

Title Strengths and challenges in conducting clinical trials in Parkinson ' s disease mild cognitive impairment

D. Aarsland, K. Kieburtz, I. Litvan, 2018 .

Functional impairment in progressive supranuclear palsy

I. Litvan, K. Duff, A. Gerstenecker, 2013, Neurology.

Research Priorities of Individuals and Caregivers With Lewy Body Dementia

B. Boeve, John-Paul Taylor, J. Quinn, 2023, Alzheimer disease and associated disorders.

Progression of Hoehn and Yahr stages in parkinsonian disorders: A clinicopathologic study

I Litvan, G K Wenning, W Poewe, 2000, Neurology.

Apolipoprotein E4 (epsilon) allele does not affect the onset or symptom severity in progressive supranuclear palsy.

A. Saunders, I. Litvan, 1998, Archives of neurology.

Medication Management Performance in Parkinson's Disease: Examination of Process Errors.

Paul E. Gilbert, J. Filoteo, M. Schmitter-Edgecombe, 2021, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

Structural MRI Correlates of Episodic Memory Processes in Parkinson’s Disease Without Mild Cognitive Impairment

J. Filoteo, D. Harrington, I. Litvan, 2015, Journal of Parkinson's disease.

Career Development Program for Underrepresented in Medicine Scholars in Academic Neurology

P. Gorelick, D. Lackland, I. Litvan, 2021, Neurology.

Understanding falls in progressive supranuclear palsy.

J. Jankovic, D. Standaert, I. Litvan, 2017, Parkinsonism & related disorders.

BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study

H. Shill, S. Sherman, D. Burn, 2005, Neurology.

Toward magnetic resonance imaging biomarkers for progressive supranuclear palsy and multisystem atrophy

I. Litvan, F. Sauvaget, 2012, Movement disorders : official journal of the Movement Disorder Society.

Clinimetric Analysis of the Motor Section of the Progressive Supranuclear Palsy Rating Scale: Reliability and Factor Analysis

G. Stebbins, D. Standaert, I. Litvan, 2016, Movement disorders clinical practice.

Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: The GenePD study

T. Gillis, J. Mysore, M. MacDonald, 2008, Movement disorders : official journal of the Movement Disorder Society.

Caregiving in progressive supranuclear palsy

Jordan Grafman, Irene Litvan, J. Grafman, 1998, Neurology.

Development and validation of a carers quality-of-life questionnaire for parkinsonism (PQoL Carers)

A. Lang, N. Quinn, D. Burn, 2015, Quality of Life Research.

Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal study.

Kelly A. Mills, A. Lang, C. Aquino, 2020, Parkinsonism & related disorders.

The meaning of a "hippo" response on the Montreal Cognitive Assessment in Parkinson's disease.

P. Eslinger, I. Litvan, S. Fox, 2013, Parkinsonism & related disorders.

Primary Health Care Providers' Knowledge Gaps on Parkinson's Disease

I. Litvan, M. Thompson, R. F. Stone, 2013, Educational gerontology.

Editorial: Neuro-covid: neuropsychological implications of the pandemic

I. Litvan, G. Prigatano, S. Palermo, 2022, Frontiers in psychology.

CBD diagnostic criteria: exclusions as important as inclusions

A. Lang, I. Litvan, M. Armstrong, 2022, Journal of Neurology, Neurosurgery, and Psychiatry.

Association of Stress-Health Factors among Parkinson's Disease Patient/Caregiving-Partner Dyads.

J. Filoteo, I. Litvan, E. Cash, 2021, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial

V. Fung, D. Standaert, R. Hauser, 2022, The Lancet Neurology.

Non-invasive Sweat-based Tracking of L-Dopa Pharmacokinetic Profiles Following an Oral Tablet Administration.

Kuldeep Mahato, I. Litvan, J. Sempionatto, 2021, Angewandte Chemie.

The clinical and pathologic hallmarks of progressive supranuclear palsy.

I Litvan, I. Litvan, 1997, Current opinion in neurology.

Methodological and Research Issues in the Evaluation of Biological Diagnostic Markers for Alzheimer’s Disease

I. Litvan, 1998, Neurobiology of Aging.

Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trial

J. Eberling, I. Litvan, D. Weintraub, 2023, Parkinsonism & Related Disorders.

Dysfunction of Ib (Autogenic) spinal inhibition in patients with progressive supranuclear palsy

M. Hallett, I. Litvan, E. Fine, 1998, Movement disorders : official journal of the Movement Disorder Society.

The Wearable Multimodal Monitoring System: A Platform to Study Falls and Near-Falls in the Real-World

Tzyy-Ping Jung, John K. Zao, Bret Kellihan, 2015, HCI.

Reply to: “Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?”

I. Litvan, P. Weissbrod, 2021, Movement disorders : official journal of the Movement Disorder Society.

Physician‐Assisted Dying: Access and Utilization in Patients with Movement Disorders

I. Litvan, E. Bayram, D. Coughlin, 2022, Movement Disorders.

Environmental Research and Public Health Environmental Exposures and Parkinson's Disease

I. Litvan, Sirisha Nandipati, 2022 .

What can artificial neural networks teach us about neurodegenerative disorders with extrapyramidal features?

I Litvan, P. Lantos, J. Hauw, 1996, Brain : a journal of neurology.

Cerebellar cognition

M. Hallett, J. Grafman, I. Litvan, 1993, Neurology.

Progressive Supranuclear Palsy and Corticobasal Degeneration.

D. Dickson, I. Litvan, K. Josephs, 2021, Advances in experimental medicine and biology.

Corticobasal Degeneration

P. Thompson, C. Marsden, I. Litvan, 2020, Definitions.

Neuropsychiatric and cognitive disorders in other parkinsonian disorders

J. Cummings, D. Aarsland, K. Chaudhuri, 2013 .

Cerebellar cognition

M. Hallett, J. Grafman, I. Litvan, 1993, Neurology.

Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms

E. Bézard, M. Jahanshahi, P. Krack, 2009, The Lancet Neurology.

A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy

M. Jahanshahi, C. Mathias, A. Lang, 2010, Movement disorders : official journal of the Movement Disorder Society.

Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options

J. Lucas, K. Frey, B. Landwehrmeyer, 2009, European journal of neurology.

Criteria for the diagnosis of corticobasal degeneration

E. Tolosa, M. Vidailhet, A. Tröster, 2016 .

Milestones in atypical and secondary Parkinsonisms

E. Tolosa, I. Litvan, G. Wenning, 2011, Movement disorders : official journal of the Movement Disorder Society.

Volumetric correlates of cognitive functioning in nondemented patients with Parkinson's disease

J. Filoteo, D. Harrington, I. Litvan, 2014, Movement disorders : official journal of the Movement Disorder Society.

Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial

Bruce H. Morimoto, C. Jack, L. Schneider, 2014, The Lancet Neurology.

Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration

A. Toga, L. Petrucelli, B. Dickerson, 2021, Neurology.

Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype

Mark T. W. Ebbert, B. Boeve, R. Uitti, 2018, Acta Neuropathologica.

Functional Magnetic-Resonance-Imaging (F-MRI) of Calculation Ability in Normal Volunteers

Jordan Grafman, Irene Litvan, D. LeBihan, 1994 .

Environmental and occupational risk factors for progressive supranuclear palsy: Case‐control study

S. Rai, I. Litvan, S. Reich, 2016, Movement disorders : official journal of the Movement Disorder Society.

Predictors of performance-based measures of instrumental activities of daily living in nondemented patients with Parkinson’s disease

I. Litvan, S. Lessig, D. Schiehser, 2013, Journal of clinical and experimental neuropsychology.